Skip to content

aTyr Pharma ATYR Quick ratio

Quick ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.3×+0.1×
Merck & Co. logo
Merck & Co.MRK
1.1×-0.2×
United Therapeutics logo
United TherapeuticsUTHR
4.5×-0.7×
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
22.3×-6.1×
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
10.4×+8.7×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
16.3×+4.3×

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$54.88M-88.2%
Enterprise value$57.17M
P/S288.8×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Calculated from aTyr Pharma’s reported figures.

Based on the most recent quarter.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is aTyr Pharma's quick ratio?
aTyr Pharma (ATYR) reported quick ratio of 5.8× in Q1 2026.
How has aTyr Pharma's quick ratio changed year-over-year?
aTyr Pharma's quick ratio decreased by 25.9% year-over-year, from 7.8× to 5.8×.
What is the long-term trend for aTyr Pharma's quick ratio?
Over 5 years (2020 to 2025), aTyr Pharma's quick ratio has grown at a -2.7% compound annual growth rate (CAGR), from 6.1× to 5.3×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.